RegisterLogin

CD22, soluble

CAT: 0209-S01-031SSize: 5 µgDry Ice: NoHazardous: No
CAT#:0209-S01-031SSize:5 µg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
CD22 is a 135 kDa B-cell restricted sialoglycoprotein that binds to oligosaccharides containing 2-6-linked sialic acid residues. It is present in the cytoplasm of nearly all B-lineage cells and is also expressed on the surface of B-cells during advance stages of differentiation. Although the exact physiological function of CD22 is unclear, it appears to play a role in B-cell activation and to act as an adhesion molecule. The potential therapeutic use of CD22 and anti-CD22 may be useful in diagnostic and/or treatment of leukemia, lymphoma, non-Hodgkin's lymphoma and certain autoimmune conditions. (Cesano A. and Gayko U. Semin. Oncol. Apr. 2003 (2) : 253-257) . Recombinant human CD22 is a soluble 75.0 kDa (666 amino acid residues) protein which corresponds to the extracellular domain of CD22.
Synonyms
CD22; SIGLEC2; SIGLEC-2
NCBI Gene ID
933
UniProt
P20273
Accession Number
NP_001762.2
Accession Number mRNA
NM_001771.3
Chromosomal Location
19q13.1
Reactivity
Human
Cross Reactivity
Human
Sequence
SKWVFEHPET LYAWEGACVW IPCTYRALDG DLESFILFHN PEYNKNTSKF DGTRLYESTK DGKVPSEQKR VQFLGDKNKN CTLSIHPVHL NDSGQLGLRM ESKTEKWMER IHLNVSERPF PPHIQLPPEI QESQEVTLTC LLNFSCYGYP IQLQWLLEGV PMRQAAVTST SLTIKSVFTR SELKFSPQWS HHGKIVTCQL QDADGKFLSN DTVQLNVKHT PKLEIKVTPS DAIVREGDSV TMTCEVSSSN PEYTTVSWLK DGTSLKKQNT FTLNLREVTK DQSGKYCCQV SNDVGPGRSE EVFLQVQYAP EPSTVQILHS PAVEGSQVEF LCMSLANPLP TNYTWYHNGK EMQGRTEEKV HIPKILPWHA GTYSCVAENI LGTGQRGPGA ELDVQYPPKK VTTVIQNPMP IREGDTVTLS CNYNSSNPSV TRYEWKPHGA WEEPSLGVLK IQNVGWDNTT IACARCNSWC SWASPVALNV QYAPRDVRVR KIKPLSEIHS GNSVSLQCDF SSSHPKEVQF FWEKNGRLLG KESQLNFDSI SPEDAGSYSC WVNNSIGQTA SKAWTLEVLY APRRLRVSMS PGDQVMEGKS ATLTCESDAN PPVSHYTWFD WNNQSLPHHS QKLRLEPVKV QHSGAYWCQG TNSVGKGRSP LSTLTVYYSP ETIGRR
Endotoxin
< 0.1 ng/µg of protein (< 1EU/µg)
Purity
> 98% by SDS-PAGE & HPLC analyses
Bioactivity
Determined by its ability to inhibit the proliferation of Raji cells. The expected ED50 for this effect is 10-17 μg/ml.
Length
666
Form
Lyophilized
Molecular Weight
75 kDa
Host or Source
CHO cells

Related Products

CatalogName
S01-050-L100CD23, soluble
S01-050-L500CD23, soluble
S01-050CD23, soluble
S01-050SCD23, soluble
S01-050-L1000CD23, soluble
S01-050-L250CD23, soluble
102-P107CD22
S01-041CD27 ligand, soluble
S01-041-L250CD27 ligand, soluble
S01-041-L100CD27 ligand, soluble

Alternative Products

CatalogName
MBS691835-01Human CD22, soluble
CEA-B046-96testsHuman Soluble Siglec-2 / CD22 ELISA Kit, PRO
477479CD22 (B-Cell Receptor CD22, CD22 Molecule)
MBS8565031-01CD22

Popular Products